Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
This study is ongoing, but not recruiting participants.
Study NCT00127881   Information provided by Genmab
First Received: August 8, 2005   Last Updated: November 11, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mycosis Fungoides
Sezary Syndrome
Additional conditions recognized in this trial
Mycoses
Syndrome
More general conditions related to this trial
Disease
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma
Lymphoma, Non-Hodgkin
Lymphoma, T-Cell
Lymphoma, T-Cell, Cutaneous
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Pathologic Processes
Interventions listed in this trial
HuMax-CD4 (zanolimumab)
Additional drug interventions recognized in this trial
Antibodies
Antibodies, Monoclonal
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Genmab


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services